AI and ChatGPT are Everywhere

There's so much buzz about ChatGPT, but how can you assist your organisation in adopting it safely and ethically? In this report Criticaleye Partner Cognician, explores whether organisations know how to utilise AI and ChatGPT effectively and what steps they can take to start assimilating AI into their businesses.

Key takeaways include:

  • Within 15 to 20 years, new automation technologies would likely eliminate 14% of the world's jobs and radically transform 32% of them.
  • Resistance is futile, we have to figure out how to best use these technologies to our advantage.
  • There’s clear risks and rewards when using AI and Chat GPT, a significant productivity opportunity, but also a risk to ensure responsible and ethical use.




Related Insights

Read, watch & listen to some of the latest thought leadership from our Community.

Click here to download this insight
The Boards' Cyber-Risk Compas...

In this insight, Criticaleye Retreat Partner Palo Alto Networks shares the 10 questions every director should ask to govern, fortify and strategise their organisation’s approach to cyber risk.

Click here to download this insight
Practical AI for CEOs

AlixPartners’ Practical AI for CEOs playbook cuts through the hype to show how leaders can turn AI ambition into measurable business value. In a market defined by rapid innovation and intensifying competition, the...

Click here to download this insight
Data Quality as the Driving F...

Data quality must be prioritised at Board level, along with initiatives to embrace the rapid changes brought by AI, and CEOs must be the driving force. This report by Criticaleye Partner Hitachi Solutions explores ...


1 2 3 4 5 6 7 8 9 10
Displaying 1 to 3 of 354




British Land NATS IBM Consulting AlixPartners Workday Worldpay Rolls-Royce Drax Group plc Aldermore Group FTSE Women Leaders Review Google Lightsource bp E.ON UK Hitachi Solutions Legal & General Salesforce Eightfold AI NatWest Group Accenture London Stock Exchange Group Concentrix Palo Alto Networks GlaxoSmithKline plc